Literature DB >> 11306764

Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998.

J M Ferro1, M Correia, C Pontes, M V Baptista, F Pita.   

Abstract

There is insufficient information on the prognosis and safety of anticoagulation in acute cerebral vein and dural sinus thrombosis (CVDST). To describe the clinical aspects and medical management of CVDST in Portuguese hospitals, to evaluate the safety of anticoagulation in this setting, and to identify subgroups of CVDST patients with different prognoses, we registered symptomatic CVDST patients admitted to Portuguese hospitals since 1980. Cases were collected from file review up to 6/95 and from consecutively admitted patients from 6/95 to 6/98. One hundred and forty-two patients were included from 20 centers (51 retrospectively and 91 prospectively). One hundred and twelve patients (79%) were anticoagulated. There were only 6 new intracranial hemorrhages (4 in anticoagulated patients) and 2 systemic hemorrhages. Nine (6%) patients died. At discharge, 96 (68%), had recovered completely and only 6 (4%) were dependent (Rankin > or = 3). Significant multivariate predictors of death/dependency were central nervous system infection as a predisposing cause (odds ratio, OR = 15.4; 95% confidence interval CI = 111-1.1), encephalopathy on admission (OR = 5.2; 95% CI = 18.7-1.5) and hemorrhage on admission CT/MR (OR = 3.6; 95% CI = 12.9-1). Significant predictors of complete recovery were no encephalopathy on admission (OR = 5; 95% CI = 12.5-2.1), age < 45 years (OR = 3.8; 95% CI = 9.2-1.6) and anticoagulation (OR = 3.8; 95% CI = 9.6-1.5). It is possible to identify CVDST patients with potential bad or good prognosis in the acute phase. Anticoagulation was safe and a predictor of complete recovery in acute CVDST. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306764     DOI: 10.1159/000047635

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  35 in total

Review 1.  Intracerebral hemorrhage from cerebral venous thrombosis.

Authors:  Jitphapa Pongmoragot; Gustavo Saposnik
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 2.  Anticoagulation for cerebral venous sinus thrombosis.

Authors:  Jonathan Coutinho; Sebastiaan Ftm de Bruijn; Gabrielle Deveber; Jan Stam
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

3.  Cerebral Venous Thrombosis and Its Clinical Diversity.

Authors:  Giovana Ennis; Nelson Domingues; Joana Silva Marques; Pedro Ribeiro; Cristina Andrade
Journal:  Cureus       Date:  2021-04-29

Review 4.  Cerebral venous thrombosis: continental disparities.

Authors:  Laith Maali; Sheema Khan; Fares Qeadan; Mahmoud Ismail; Davana Ramaswamy; Vishnumurthy S Hedna
Journal:  Neurol Sci       Date:  2017-08-14       Impact factor: 3.307

Review 5.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

Review 6.  Duration of anticoagulation after cerebral venous sinus thrombosis.

Authors:  Frances Caprio; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

7.  Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study.

Authors:  Jean-Marc Bugnicourt; Bertrand Roussel; Blaise Tramier; Chantal Lamy; Olivier Godefroy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-22       Impact factor: 10.154

8.  Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies.

Authors:  N Yesilot; S Bahar; S Yilmazer; M Mutlu; M Kurtuncu; R Tuncay; O Coban; G Akman-Demir
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

9.  Cerebral venous thrombosis presenting with subdural haematoma as first presentation for systemic lupus erythematosus with negative antiphospholipid antibodies.

Authors:  Ayman Alboudi; Pournamy Sarathchandran; Suhail Alrukn; Abubaker Al Madani
Journal:  BMJ Case Rep       Date:  2014-07-30

Review 10.  Cerebral venous sinus thrombosis: update on diagnosis and management.

Authors:  José M Ferro; Patrícia Canhão
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.